TABI, Katarína, Abnashi Singh RANDHAWA, Fiona CHOI, Zamina MITHANI, Friederike ALBERS, Maren SCHNIEDER, Mohammadali NIKOO, Daniel VIGO, Kerry JANG, Regina DEMLOVÁ a Michael KRAUSZ. Mobile Apps for Medication Management: Review and Analysis. JMIR MHEALTH AND UHEALTH. TORONTO: JMIR PUBLICATIONS, INC, 2019, roč. 7, č. 9, s. 1-14. ISSN 2291-5222. Dostupné z: https://dx.doi.org/10.2196/13608.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název Mobile Apps for Medication Management: Review and Analysis
Autoři TABI, Katarína (703 Slovensko, garant, domácí), Abnashi Singh RANDHAWA (124 Kanada), Fiona CHOI (124 Kanada), Zamina MITHANI (124 Kanada), Friederike ALBERS (528 Nizozemské království), Maren SCHNIEDER (826 Velká Británie a Severní Irsko), Mohammadali NIKOO (124 Kanada), Daniel VIGO (124 Kanada), Kerry JANG (124 Kanada), Regina DEMLOVÁ (203 Česká republika, domácí) a Michael KRAUSZ (124 Kanada).
Vydání JMIR MHEALTH AND UHEALTH, TORONTO, JMIR PUBLICATIONS, INC, 2019, 2291-5222.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor 30104 Pharmacology and pharmacy
Stát vydavatele Kanada
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 4.313
Kód RIV RIV/00216224:14110/19:00110240
Organizační jednotka Lékařská fakulta
Doi http://dx.doi.org/10.2196/13608
UT WoS 000485323700001
Klíčová slova anglicky eHealth; mHealth; drugs; pharmaceuticals; therapy
Štítky 14110516, rivok
Příznaky Mezinárodní význam, Recenzováno
Změnil Změnila: Mgr. Tereza Miškechová, učo 341652. Změněno: 27. 1. 2021 12:22.
Anotace
Background: Pharmacotherapy remains one of the major interventional strategies in medicine. However, patients from all age groups and conditions face challenges when taking medications, such as integrating them into the daily routine, understanding their effects and side effects, and monitoring outcomes. In this context, a reliable medication management tool adaptable to the patient's needs becomes critical. As most people have a mobile phone, mobile apps offer a platform for such a personalized support tool available on the go. Objective: This study aimed to provide an overview of available mobile apps, focusing on those that help patients understand and take their medications. We reviewed the existing apps and provided suggestions for future development based on the concept understand and manage, instead of the conventional adhere to medication. This concept aims to engage and empower patients to be in charge of their health, as well as see medication as part of a broader clinical approach, working simultaneously with other types of interventions or lifestyle changes, to achieve optimal outcomes. Methods: We performed a Web search in the iOS Apple App Store and Android Google Play Store, using 4 search terms: medication management, pill reminder, medication health monitor, and medication helper. We extracted information from the app store descriptions for each eligible app and categorized into the following characteristics: features, author affiliation, specialty, user interface, cost, and user rating. In addition, we conducted Google searches to obtain more information about the author affiliation. Results: A total of 328 apps (175 Android and 153 iOS) were categorized. The majority of the apps were developed by the software industry (73%, 11/15), a minority of them were codeveloped by health care professionals (15%, 3/20) or academia (2.1%; 7/328). The most prevalent specialty was diabetes (23 apps). Only 7 apps focused on mental health, but their content was highly comprehensive in terms of features and had the highest prevalence of the education component. The most prevalent features were reminder, symptom tracker, and ability to share data with a family member or doctor. In addition, we highlighted the features considered innovative and listed practical suggestions for future development and innovations. Conclusions: We identified detailed characteristics of the existing apps, with the aim of informing future app development. Ultimately, the goal was to provide users with effective mobile health solutions, which can be expected to improve their engagement in the treatment process and long-term well-being. This study also highlighted the need for improved standards for reporting on app stores. Furthermore, it underlined the need for a platform to offer health app users an ongoing evaluation of apps by health professionals in addition to other users and to provide them with tools to easily select an appropriate and trustworthy app.
Návaznosti
LM2015090, projekt VaVNázev: Český národní uzel Evropské sítě infrastruktur klinického výzkumu (Akronym: CZECRIN)
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, CZECRIN - Český národní uzel Evropské sítě infrastruktur klinického výzkumu
MUNI/A/1132/2017, interní kód MUNázev: Behaviorální psychofarmakologie a farmakokinetika v preklinickém výzkumu léčiv
Investor: Masarykova univerzita, Behaviorální psychofarmakologie a farmakokinetika v preklinickém výzkumu léčiv, DO R. 2020_Kategorie A - Specifický výzkum - Studentské výzkumné projekty
VytisknoutZobrazeno: 15. 7. 2024 19:22